Fertility preservation in borderline ovarian tumors

被引:0
|
作者
Munoz, S. Peon [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Serv Ginecol & Obstet, Equipo Reprod Asistida Fundacio Puigvert, Barcelona, Spain
关键词
Borderline ovarian tumor; Fertility preservation; Fertility-sparing surgery; Oocyte vitrification; Ovarian tissue cryopreservation; In vitro maturation; IN-VITRO FERTILIZATION; CONSERVATIVE MANAGEMENT; SPARING TREATMENT; WOMEN; CANCER; SURGERY; RISK; AGE; OUTCOMES; OOCYTES;
D O I
10.1016/j.gine.2023.100933
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Borderline ovarian tumors (BOTs) are defined as "tumors of low malignant potential". These are epithelial neoplasms that debut mainly in young women, and are usually diagnosed in the initial stages of the disease. The main key to its treatment is surgery, thus compromising the fertility of the patient who has not fulfilled her reproductive desire. In general, the choice of surgery for BOTs should consider the characteristics of the tumor, the patient's fertility desires, and the extent of the disease. The decisions made in this regard must be individualized and advised by a multidisciplinary team. Fertility preservation (FP) plays an important role in the management of these patients, and there are different strategies to improve and maintain their quality of life. Reproductive counseling should be an integral part of clinical management, with risks and benefits carefully considered. Given its low incidence, there is little literature on the matter, requiring well-designed prospective studies to address specific fertility problems both in the initial diagnosis and in recurrences of patients with BOTs. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Fertility preservation in patients with borderline ovarian tumors
    Kreuzer V.K.
    Fehm T.N.
    [J]. Der Gynäkologe, 2018, 51 (11): : 946 - 950
  • [2] Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors
    Vancraeynest, Eveline
    Moerman, Philippe
    Leunen, Karin
    Amant, Frederic
    Neven, Patrick
    Vergote, Ignace
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (08) : 1399 - 1406
  • [3] Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors
    Helpman, Limor
    Beiner, Mario E.
    Aviel-Ronen, Sarit
    Perri, Tamar
    Hogen, Liat
    Jakobson-Setton, Ariella
    Ben-Baruch, Gilad
    Korach, Jacob
    [J]. FERTILITY AND STERILITY, 2015, 104 (01) : 138 - 144
  • [4] Preservation of fertility in surgery of benign and borderline malignant ovarian tumors
    Guillaume, A.
    Pirrello, O.
    [J]. JOURNAL OF VISCERAL SURGERY, 2018, 155 : S17 - S21
  • [5] Role of fertility preservation therapy in patients with borderline ovarian tumors
    Westermann, T.
    Heitz, F.
    Ataseven, B.
    Pauly, N.
    Moubarak, M.
    Strojna, A.
    Kaiser, S.
    Welz, J.
    Imterat, M.
    Concin, N.
    Dagres, T.
    Vrentas, V.
    Traut, A.
    Plett, H.
    Du, Bois A.
    Harter, P.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E181 - E181
  • [6] Fertility preservation for women with borderline ovarian tumors: fertility-sparing surgery
    Kim, S. Samuel
    [J]. FERTILITY AND STERILITY, 2021, 115 (01) : 83 - 84
  • [7] Fertility preservation in patients with borderline ovarian tumors: safety and reproductive outcomes
    Shai, D.
    Rossella, M.
    Cioffi, R.
    Ohayon, A.
    Helpman, L.
    Papaleo, E.
    Vanni, V. S.
    Bergamini, A.
    Candiani, M.
    Korach, J.
    Mangili, G.
    Meirow, D.
    [J]. HUMAN REPRODUCTION, 2024, 39
  • [8] Borderline ovarian tumors and fertility
    Nam, Joo-Hyun
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (03) : 227 - 234
  • [9] Second fertility preservation surgery for early relapse of seromucinous borderline ovarian tumors
    Kanno, Motoko
    Iwamoto, Hideki
    Umezawa, Satoshi
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [10] Borderline ovarian tumors: Long-term survival and preservation of fertility.
    Gercovich, Natasha
    Gerardi, Carlos Garcia
    Deza, Ernesto Gil
    Morgenfeld, Eduardo L.
    Rivarola, Edgardo G. J.
    Gercovich, Felipe G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)